Clinical Trial Update: Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated NOX-H94 for efficacy in anemia of chronic disease in patients with cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Disease

Drugs mentioned

• NOX-H94

Snippet

Sponsor: TME Pharma AG | Conditions: Anemia of Chronic Disease | Phase 2 | Status: COMPLETED